SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-023519
Filing Date
2022-11-09
Accepted
2022-11-09 07:31:34
Documents
77
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mirm-20220930.htm   iXBRL 10-Q 4140185
2 EX-31.1 mirm-ex31_1.htm EX-31.1 21863
3 EX-31.2 mirm-ex31_2.htm EX-31.2 22040
4 EX-32.1 mirm-ex32_1.htm EX-32.1 12500
5 EX-32.2 mirm-ex32_2.htm EX-32.2 12674
  Complete submission text file 0000950170-22-023519.txt   13666930

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mirm-20220930_cal.xml EX-101.CAL 61057
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mirm-20220930_pre.xml EX-101.PRE 474223
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mirm-20220930_lab.xml EX-101.LAB 630132
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mirm-20220930_def.xml EX-101.DEF 305023
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mirm-20220930.xsd EX-101.SCH 81837
71 EXTRACTED XBRL INSTANCE DOCUMENT mirm-20220930_htm.xml XML 2731577
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38981 | Film No.: 221370676
SIC: 2834 Pharmaceutical Preparations